A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

Clinical trial NCT06539507 · RECRUITING

Trial details

NCT number: NCT06539507
Sponsor: BioCryst Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Netherton Syndrome

Start date: 2024-09-26
Primary completion: 2026-10-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.